Join the Deep Vein Thrombosis group to help and get support from people like you.
Deep Vein Thrombosis News
Dangerous Blood Clot Sidelines NBA Star Victor Wembanyama for the Season
FRIDAY, Feb. 21, 2025 – One of the NBA's most exciting rising stars will spend the rest of the 2024-2025 season on the bench. Victor Wembanyama, the San Antonio Spurs' 7-foot 3-inch phenom, was...
Venous Thromboembolism Risk Higher for Certain Hormonal Contraceptives
THURSDAY, Feb. 13, 2025 – Venous thromboembolism (VTE) risk varies across hormonal contraceptives, according to a research letter published online Feb. 10 in the Journal of the American Medical...
Air Pollution Could Be Raising Your Odds for a Blood Clot
FRIDAY, Dec. 13, 2024 – Breathing in smoggy air over time can significantly raise a person's chances for dangerous blood clots, new research shows. “What’s striking from our study is the increase in ...
Higher Ambient Levels of Air Pollutants Linked to Increased VTE Risk
FRIDAY, Dec. 13, 2024 – Higher ambient levels of air pollutants are associated with increased risk of venous thromboembolism (VTE), according to a study published online Dec. 12 in Blood. Pamela...
ASH: Reduced-Dose Anticoagulants Not Noninferior for Recurrent VTE
FRIDAY, Dec. 6, 2024 – Noninferiority of reduced- versus full-dose anticoagulants cannot be proven in patients with venous thromboembolism who need extended anticoagulation, according to a study to...
Bleeding Risk Increased With NSAID Use for VTE Patients Receiving Anticoagulants
MONDAY, Nov. 18, 2024 – Patients with venous thromboembolism (VTE) initiating oral anticoagulants have an increased risk for bleeding when using nonsteroidal anti-inflammatory drugs (NSAIDs),...
Just Standing More Probably Won't Help Your Heart
THURSDAY, Oct. 17, 2024 – Got yourself a standing desk because you know sitting is unhealthy? It might be the wrong move, new research suggests. The study of over 83,000 British adults who wore...
Risk for Venous Thromboembolism Up for Those With Sickle Cell Trait
THURSDAY, Sept. 12, 2024 – Individuals with sickle cell trait (SCT) have an increased risk for venous thromboembolism (VTE), according to a study published online Sept. 12 in Blood Advances....
FDA Medwatch Alert: Eliquis (apixaban) 5 mg tablets: Recall One Lot- Bottle labeled as Eliquis 5 mg was found to contain Eliquis 2.5 mg tablets
ISSUE: Bristol-Myers Squibb Company is voluntarily recalling one lot (#HN0063) of Eliquis 5 mg tablets to the consumer level. This lot was distributed nationwide in the U.S. to wholesalers and retail...
FDA Approves Savaysa (edoxaban) to Prevent Embolic Events in Non-Valvular Atrial Fibrillation
January 8, 2015 – The U.S. Food and Drug Administration today approved the anti-clotting drug Savaysa (edoxaban tablets) to reduce the risk of stroke and dangerous blood clots (systemic embolism) in...
FDA Approves Eliquis (apixaban) for the Treatment of Deep Vein Thrombosis and Pulmonary Embolism
Thursday, August 21, 2014 - Bristol-Myers Squibb Company (NYSE: BMY) and Pfizer Inc. (NYSE: PFE) today announced the U.S. Food and Drug Administration (FDA) has approved a Supplemental New Drug...
FDA Approves Pradaxa for Deep Venous Thrombosis and Pulmonary Embolism
Ridgefield, CT, April 7, 2014 – Boehringer Ingelheim Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved Pradaxa® (dabigatran etexilate mesylate) for th...
FDA Medwatch Alert: Heparin: Drug Safety Communication - Important change to heparin container labels to clearly state the total drug strength
ISSUE: FDA is notifying health care professionals, caregivers, and patients about a change to the container and carton labels for heparin products. This label change will require manufacturers of...
FDA Expands Use of Xarelto to Treat, Reduce Recurrence of Blood Clots
November 2, 2012 – The U.S. Food and Drug Administration today expanded the approved use of Xarelto (rivaroxaban) to include treating deep vein thrombosis (DVT) or pulmonary embolism (PE), and to...
Further information
Related condition support groups
Deep Vein Thrombosis - Prophylaxis, Deep Vein Thrombosis - Recurrent Event, Deep Vein Thrombosis - First Event